There is also increasing evidence to investigate dose-escalated RT in patients with glioblastoma, particularly in subgroups that do not receive TMZ or those who are known to have unmethylated DNA repair enzyme O-6-methylguanine-DNA methyltransferase (MGMT) [19]. This evidence concerns the gene MGMT and glioblastoma.